Rapamycin enhances lifespan: At last, an advantage for transplant recipients?
Article
Geissler, E. K. (2009) Rapamycin enhances lifespan: At last, an advantage for transplant recipients? Nephrology Dialysis Transplantation 24 (12), pp. 3623-3625.Alternative links to fulltext
Involved Institutions
Details
| Item type | Article | ||||
| Journal or Publication Title | Nephrology Dialysis Transplantation | ||||
| Publisher | OXFORD UNIV PRESS | ||||
| Place of Publication | OXFORD | ||||
| Volume | 24 | ||||
| Number of Issue or Book Chapter | 12 | ||||
| Page Range | pp. 3623-3625 | ||||
| Date | 2009 | ||||
| Date of publication | 19 Dec 2024 11:58 | ||||
| Institutions | Medicine > Lehrstuhl für Chirurgie | ||||
| Identification Number |
| ||||
| Keywords | AMES DWARF MICE; TOR PATHWAY; SIGNALING PATHWAY; EXTENSION; RESTRICTION; ELEGANS; TARGET; GROWTH; CANCER; MOUSE; rapamycin; lifespan; renal transplantation; TOR | ||||
| Dewey Decimal Classification | 600 Technology > 610 Medical sciences Medicine | ||||
| Status | Published | ||||
| Refereed | Yes, this version has been refereed | ||||
| Created at the University of Regensburg | Yes | ||||
| Item ID | 66735 |
Export bibliographical data
Owner only: item control page
Altmetric
Altmetric